Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: December 2024

D-Wave Quantum Inc. (NYSE: QBTS) Completes Q3 2024 with Key Product Milestones, New Partnerships and Technological Breakthroughs

Posted on December 3, 2024 by MissionIR

D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the first commercial provider of quantum computers, recently announced Q3 2024 business results, highlighting several key operational milestones and technological achievements, including new partnerships and developments … Continue reading →

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

Annovis Bio Inc. (NYSE: ANVS) to Present Recent Achievements and 2025 Strategic Outlook During Upcoming Live Investor Webcast

Posted on December 3, 2024 by MissionIR

Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), will hold a live investor webcast on Dec. 11, 2024, at 4:30 p.m. EST, to … Continue reading →

Posted in Annovis Bio Inc. ANVS | Leave a comment

Financial Discipline and EM Client Expansion Drive Q3 Improvements for SuperCom Ltd. (NASDAQ: SPCB)

Posted on December 2, 2024 by MissionIR

Electronic monitoring (“EM”) technology developer SuperCom (NASDAQ: SPCB) reported the success of its international expansion initiatives recently in a Q3 earnings call that included details about increased revenue and gross profit margin. SuperCom has developed EM technology under its PureSecurity platform, which … Continue reading →

Posted in SuperCom Ltd. SPCB | Leave a comment